Injectable sustained release implant having a bioerodible matrix core and a bioerodible skin
Details for Australian Patent Application No. 2004292957 (hide)
International Classifications
Event Publications
15 June 2006 PCT application entered the National Phase
PCT publication WO2005/051234 Priority application(s): WO2005/051234
29 June 2006 Change of Name(s) of Applicant(s), Section 104
Control Delivery Systems, Inc. The name of the applicant has been changed to pSivida, Inc.
16 July 2009 Alteration of Name
The name of the applicant has been altered to pSivida US Inc.
9 September 2010 Application Accepted
Published as AU-B-2004292957
6 January 2011 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 30 Nov 2010. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000 2005
28 April 2011 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 30 Nov 2010
12 May 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004292956-Compositions for achieving benefits in skin using key cellular metabolic intermediates
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser